ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
This Quarter Return
+13.5%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$7.83B
AUM Growth
+$7.83B
(+40%)
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
20.99%
Top 10 Holdings %
Top 10 Hldgs %
20.17%
Holding
1,510
New
258
Increased
732
Reduced
397
Closed
118
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$175M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$130M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$100M |
| 4 |
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
$94.1M |
| 5 |
WEEK
Roundhill Weekly T-Bill ETF
WEEK
|
$86.3M |
Top Sells
| 1 |
Vanguard Ultra-Short Bond ETF
VUSB
|
$82.5M |
| 2 |
NVIDIA
NVDA
|
$63.2M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$62.1M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$60.4M |
| 5 |
Tesla
TSLA
|
$53M |
Sector Composition
| 1 | Technology | 16.08% |
| 2 | Energy | 8.44% |
| 3 | Communication Services | 8.07% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Financials | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Immatics
IMTX
$662M
| – | – |
-25,580
| Closed | -$115K |
|
1477
Inhibrx
INBX
$403M
| – | – |
-9,138
| Closed | -$128K |
|
1478
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-34,061
| Closed | -$113K |
|
|
IPHA
1479
Innate Pharma
IPHA
$186M
| – | – |
-62,752
| Closed | -$112K |
|
|
ITOS
1480
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-17,308
| Closed | -$103K |
|
1481
Janux Therapeutics
JANX
$1.38B
| – | – |
-4,043
| Closed | -$109K |
|
1482
SEACOR Marine Holdings
SMHI
$173M
| – | – |
-17,233
| Closed | -$87.2K |
|
1483
Keros Therapeutics
KROS
$640M
| – | – |
-6,014
| Closed | -$61.3K |
|
1484
Kontoor Brands
KTB
$4.42B
| – | – |
-308
| Closed | -$19.8K |
|
1485
Kura Oncology
KURA
$732M
| – | – |
-17,474
| Closed | -$115K |
|
1486
Kymera Therapeutics
KYMR
$3.1B
| – | – |
-3,693
| Closed | -$101K |
|
1487
Legend Biotech
LEGN
$6.64B
| – | – |
-3,358
| Closed | -$114K |
|
1488
Logitech
LOGI
$15.4B
| – | – |
-214
| Closed | -$18.1K |
|
1489
Open Lending Corp
LPRO
$268M
| – | – |
-77,055
| Closed | -$213K |
|
1490
Lyell Immunopharma
LYEL
$220M
| – | – |
-246,349
| Closed | -$133K |
|
1491
Medifast
MED
$153M
| – | – |
-17,491
| Closed | -$236K |
|
1492
MacroGenics
MGNX
$121M
| – | – |
-58,434
| Closed | -$74.2K |
|
1493
Merus
MRUS
$5.04B
| – | – |
-2,698
| Closed | -$114K |
|
1494
NextDecade
NEXT
$2.74B
| – | – |
-22,540
| Closed | -$175K |
|
1495
NOV
NOV
$4.82B
| – | – |
-18,201
| Closed | -$277K |
|
1496
Nurix Therapeutics
NRIX
$723M
| – | – |
-9,145
| Closed | -$109K |
|
1497
Nuvation Bio
NUVB
$1.08B
| – | – |
-60,951
| Closed | -$107K |
|
1498
Nuvalent
NUVL
$5.74B
| – | – |
-1,654
| Closed | -$117K |
|
1499
Opko Health
OPK
$1.1B
| – | – |
-338,948
| Closed | -$563K |
|
1500
Precigen
PGEN
$1.42B
| – | – |
-71,566
| Closed | -$107K |
|